Biotricity Common Stock Total Equity from 2010 to 2026

BTCY Stock  USD 0.28  0.02  6.67%   
Biotricity Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity will likely drop to about 27.8 K in 2026. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2014-06-30
Previous Quarter
48.9 K
Current Value
49.7 K
Quarterly Volatility
11.8 K
 
Yuan Drop
 
Covid
Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 6.3 M or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0035 or Days Sales Outstanding of 141. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
  
Build AI portfolio with Biotricity Stock
Check out the analysis of Biotricity Correlation against competitors.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Latest Biotricity's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Biotricity over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Biotricity's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biotricity's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Biotricity Common Stock Total Equity Regression Statistics

Arithmetic Mean26,154
Geometric Mean19,558
Coefficient Of Variation57.43
Mean Deviation12,933
Median31,858
Standard Deviation15,020
Sample Variance225.6M
Range40.4K
R-Value0.86
Mean Square Error62.2M
R-Squared0.74
Slope2,561
Total Sum of Squares3.6B

Biotricity Common Stock Total Equity History

202627.8 K
202544.9 K
202039 K
201936.4 K
201835.4 K
201731.9 K
201626.3 K

About Biotricity Financial Statements

Biotricity investors use historical fundamental indicators, such as Biotricity's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity44.9 K27.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.